Physician

Teresa Veronica Levitski-Heikkila, MD

According to 2025 Medicare claims, Teresa Levitski-Heikkila, MD (NPI: 1366408536) practices internal medicine in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is CENTRACARE CLINIC (NPI: 1043212665; TIN: 411806657) and primary practice location at 56303-1738. Levitski-Heikkila is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Prairie Vista Care Organization (ACO ID: A3578), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), Essentia Health ACO, Inc. (ACO ID: A5617), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Levitski-Heikkila's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 344 traditional Medicare patients, billed 1,420 HCPCS/CPT codes, and received $140,774 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,854 prescription claims across 329 beneficiaries totaling $143,562 in drug costs, led by Veltassa (Patiromer Calcium Sorbitex). DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $245,345 to $140,774. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $379,442 to $143,562. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	561	2,593	$245,345
2016	510	2,271	$219,902
2017	542	2,209	$220,256
2018	461	1,509	$111,510
2019	471	1,607	$138,505
2020	429	1,813	$167,195
2021	393	2,002	$178,721
2022	378	1,966	$149,527
2023	350	2,001	$141,513
2024	344	1,420	$140,774

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	338	2,836	$379,442
2016	325	2,966	$325,890
2017	333	3,465	$408,063
2018	319	2,218	$203,947
2019	284	1,282	$77,689
2020	281	1,766	$151,648
2021	300	2,095	$147,048
2022	339	2,134	$137,550
2023	316	1,896	$174,117
2024	329	1,854	$143,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	83	863	$66,131
2016	89	914	$58,782
2017	91	822	$56,007
2018	46	530	$45,735
2019	N/R	86	$7,935
2020	N/R	99	$9,594
2021	N/R	12	$3,100
2022	N/R	N/R	N/R
2023	N/R	11	$138
2024	N/R	11	$207

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	37	252	$265
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	156	223	$117
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	37	66	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	45	48	$85
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	41	75	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Veltassa	Patiromer Calcium Sorbitex	24	1,214	$28,430
Farxiga	Dapagliflozin Propanediol	17	1,290	$23,128
Jardiance	Empagliflozin	20	880	$15,062
Lokelma	Sodium Zirconium Cyclosilicate	16	960	$11,488
Calcitriol	Calcitriol	419	29,717	$7,049

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	11	$207

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Teresa Veronica Levitski-Heikkila, MD?

Tedicare shows public-source Medicare data for Teresa Veronica Levitski-Heikkila, MD (NPI 1366408536), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Teresa Veronica Levitski-Heikkila, MD have ACO affiliation data?

Teresa Veronica Levitski-Heikkila, MD is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Prairie Vista Care Organization (MSSP, ACO ID A3578), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), Essentia Health ACO, Inc. (MSSP, ACO ID A5617), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Teresa Veronica Levitski-Heikkila, MD?

Teresa Veronica Levitski-Heikkila, MD is linked to CENTRACARE CLINIC (billing NPI 1043212665) in the available physician profile data.

Does Teresa Veronica Levitski-Heikkila, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.